- Home
- ATCX vs MODD Comparison
ATCX vs MODD Comparison
Compare ATCX & MODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATCX | MODD |
|---|---|---|
| Founded | 2016 | 1998 |
| Country | Brazil | United States |
| Employees | 13 | N/A |
| Industry | | Industrial Specialties |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.5M | 23.5M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | ATCX | MODD |
|---|---|---|
| Price | $3.78 | $4.72 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $13.75 | N/A |
| AVG Volume (30 Days) | ★ 22.9K | 16.1K |
| Earning Date | 03-16-2023 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 34.62 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $827,667.00 | N/A |
| Revenue Next Year | $166.45 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.77 | $0.12 |
| 52 Week High | $14.01 | $6.16 |
Technical Indicators
Market Signals| Indicator | ATCX | MODD |
|---|---|---|
| Relative Strength Index (RSI) | 26.04 | 53.63 |
| Support Level | N/A | $4.41 |
| Resistance Level | $5.62 | $5.89 |
| Average True Range (ATR) | 0.35 | 0.58 |
| MACD | -0.07 | 0.03 |
| Stochastic Oscillator | 3.45 | 58.04 |
Price Performance
Historical ComparisonAbout ATCX Atlas Critical Minerals Corporation Common Stock
Atlas Critical Minerals Corp is a mineral exploration and development company focused on critical minerals projects and properties in Brazil. The company's portfolio principally includes mineral properties for rare earths, graphite, titanium, copper, uranium, and nickel. It also owns mineral rights for iron ore, quartzite, gold, and diamond properties. The company's project portfolio includes the Alto Paranaiba, Malacacheta, Arcos, Goias, Tocantins, Rio Piracicaba, and other projects.
About MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.